Cargando…

International Consensus Guidance for Management of Myasthenia Gravis: 2020 Update

OBJECTIVE: To update the 2016 formal consensus-based guidance for the management of myasthenia gravis (MG) based on the latest evidence in the literature. METHODS: In October 2013, the Myasthenia Gravis Foundation of America appointed a Task Force to develop treatment guidance for MG, and a panel of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Narayanaswami, Pushpa, Sanders, Donald B., Wolfe, Gil, Benatar, Michael, Cea, Gabriel, Evoli, Amelia, Gilhus, Nils Erik, Illa, Isabel, Kuntz, Nancy L., Massey, Janice, Melms, Arthur, Murai, Hiroyuki, Nicolle, Michael, Palace, Jacqueline, Richman, David, Verschuuren, Jan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2021
Materias:	Views & Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7884987/ https://www.ncbi.nlm.nih.gov/pubmed/33144515 http://dx.doi.org/10.1212/WNL.0000000000011124

Ejemplares similares

International consensus guidance for management of myasthenia gravis: Executive summary
por: Sanders, Donald B., et al.
Publicado: (2016)

Editorial: News and Views in the Management of Myasthenia Gravis
por: Evoli, Amelia, et al.
Publicado: (2021)

Myasthenia gravis
por: Juel, Vern C, et al.
Publicado: (2007)

Controversies in Ocular Myasthenia Gravis
por: Evoli, Amelia, et al.
Publicado: (2020)

Myasthenia Gravis
por: Aarli, Johan A., et al.
Publicado: (2011)

Advances and challenges in the treatment of myasthenia gravis
por: Schneider-Gold, Christiane, et al.
Publicado: (2021)

Editorial: Phenotypes of myasthenia gravis
por: Li, Hai-Feng, et al.
Publicado: (2022)

User Involvement in Myasthenia Gravis Research
por: Gilhus, Nils Erik, et al.
Publicado: (2022)

Immunoactive treatment for myasthenia gravis; a Chinese experience
por: Gilhus, Nils Erik
Publicado: (2020)

Myasthenia gravis, respiratory function, and respiratory tract disease
por: Gilhus, Nils Erik
Publicado: (2023)

Management of Juvenile Myasthenia Gravis
por: O'Connell, Karen, et al.
Publicado: (2020)

Guidance for the management of myasthenia gravis (MG) and Lambert-Eaton myasthenic syndrome (LEMS) during the COVID-19 pandemic
por: Jacob, Saiju, et al.
Publicado: (2020)

Myasthenia Gravis Can Have Consequences for Pregnancy and the Developing Child
por: Gilhus, Nils Erik
Publicado: (2020)

Characterization of B cells in muscle-specific kinase antibody myasthenia gravis
por: Guptill, Jeffrey T., et al.
Publicado: (2015)

Benefit and danger from immunotherapy in myasthenia gravis
por: Rodolico, Carmelo, et al.
Publicado: (2021)

Long‐term safety and efficacy of eculizumab in generalized myasthenia gravis
por: Muppidi, Srikanth, et al.
Publicado: (2019)

Myasthenia gravis: a clinical-immunological update
por: Binks, Sophie, et al.
Publicado: (2015)

Complicating autoimmune diseases in myasthenia gravis: a review
por: Nacu, Aliona, et al.
Publicado: (2015)

Thymectomy in Non-Thymomatous Myasthenia Gravis: Does An RCT Solve The 75-Year-Old Controversy?
por: Singh, Nishita, et al.
Publicado: (2020)

Myasthenia gravis: Antigen presentation by thymoma epithelial cells
por: Gilhus, N.E., et al.
Publicado: (1994)

Myasthenia Gravis: A Review of Available Treatment Approaches
por: Gilhus, Nils Erik, et al.
Publicado: (2011)

MYASTHENIA GRAVIS CRISIS TRIGGERED BY COVID-19
por: Fares, Elie, et al.
Publicado: (2020)

Epidemiological evidence for a hereditary contribution to myasthenia gravis: a retrospective cohort study of patients from North America
por: Green, Joshua D, et al.
Publicado: (2020)

Muscle-Specific Kinase Myasthenia Gravis
por: Borges, Lucia S., et al.
Publicado: (2020)

Insights into the Classification of Myasthenia Gravis
por: Akaishi, Tetsuya, et al.
Publicado: (2014)

Diagnosis and therapy of myasthenia gravis—the patients’ perspective: a cross-sectional study
por: Sobierajski, Tomasz, et al.
Publicado: (2023)

Occurrence and severity of myasthenic crisis in an unselected Turkish cohort of patients with myasthenia gravis
por: Ozyurt Kose, Selen, et al.
Publicado: (2023)

Matrix Metalloproteinase-3 in Myasthenia Gravis Compared to Other Neurological Disorders and Healthy Controls
por: Luckman, Steven P., et al.
Publicado: (2011)

Correlation of Quantitative Myasthenia Gravis and Myasthenia Gravis Activities of Daily Living scales in the MGTX study
por: McPherson, Tarrant, et al.
Publicado: (2020)

Reappraisal of Oral Steroid Therapy for Myasthenia Gravis
por: Imai, Tomihiro, et al.
Publicado: (2020)

Total drug treatment and comorbidity in myasthenia gravis: a population-based cohort study
por: Andersen, J B, et al.
Publicado: (2014)

Repeated Acetylcholine Receptor Antibody-Concentrations and Association to Clinical Myasthenia Gravis Development
por: Heldal, Anne Taraldsen, et al.
Publicado: (2014)

Myasthenia Gravis
Publicado: (1905)

Myasthenia Gravis
por: Wilson, Andrew
Publicado: (1952)

Myasthenia Gravis
por: Bramwell, Edwin
Publicado: (1901)

Serological Immunoglobulin-Free Light Chain Profile in Myasthenia Gravis Patients
por: Basile, Umberto, et al.
Publicado: (2018)

Treatment of Myasthenia Gravis Based on Its Immunopathogenesis
por: Kim, Jee Young, et al.
Publicado: (2011)

Addressing Outcome Measure Variability in Myasthenia Gravis Clinical Trials
por: Guptill, Jeffrey T., et al.
Publicado: (2023)

COVID-19-associated risks and effects in myasthenia gravis (CARE-MG)
por: Muppidi, Srikanth, et al.
Publicado: (2020)

Treating muscle-specific kinase myasthenia gravis from the inside out
por: Huijbers, Maartje G., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_3ene9737cq1gsb0umokgul380i